EFFECT OF METABOLIC FACTORS AND BLOOD-PRESSURE ON KIDNEY-FUNCTION IN PROTEINURIC TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS

被引:66
作者
HASSLACHER, C
BOSTEDTKIESEL, A
KEMPE, HP
WAHL, P
机构
[1] Department of Endocrinology and Metabolism, Medical University Clinic, Heidelberg, D-69115
关键词
DIABETIC NEPHROPATHY; TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS; PROTEINURIA; LIPIDS; BLOOD PRESSURE; METABOLIC CONTROL;
D O I
10.1007/BF02374498
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Decline of kidney function with time and its influencing factors were investigated in the present longitudinal study in Type 2 (non-insulin-dependent) diabetic patients with clinical diabetic nephropathy. Compared to a control group of Type 2 diabetic patients without proteinuria, the proteinuric patients showed a higher prevalence of hypertension, higher systolic blood pressure values and serum triglyceride levels. The annual loss of glomerular kidney function was much higher in the proteinuric patients (5.3 ml.min-1.1.73 m2) than in the control subjects (0.9 ml.min-1.1.73 m2). Correlation analyses revealed a close correlation between the annual decrease of kidney function and the factors, systolic and diastolic blood pressure, triglyceride and postprandial blood glucose level as well as body mass index. Regression analyses showed for the first time that in addition to the systolic blood pressure and metabolic control, the triglyceride level is also an independent factor influencing the progression of nephropathy. Higher values of these parameters were associated with a more rapid deterioration of kidney function.
引用
收藏
页码:1051 / 1056
页数:6
相关论文
共 31 条
  • [1] DYSLIPOPROTEINEMIA IN DIABETIC RENAL-FAILURE
    ATTMAN, PO
    NYBERG, G
    WILLIAMOLSSON, T
    KNIGHTGIBSON, C
    ALAUPOVIC, P
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (06) : 1381 - 1389
  • [2] TREATMENT OF ARTERIAL-HYPERTENSION IN DIABETIC HUMANS - IMPORTANCE OF THERAPEUTIC SELECTION
    BAKRIS, GL
    BARNHILL, BW
    SADLER, R
    [J]. KIDNEY INTERNATIONAL, 1992, 41 (04) : 912 - 919
  • [3] BENEFICIAL-EFFECTS OF ANGIOTENSIN CONVERTING ENZYME-INHIBITION ON RENAL-FUNCTION IN PATIENTS WITH DIABETIC NEPHROPATHY
    BJORCK, S
    NYBERG, G
    MULEC, H
    GRANERUS, G
    HERLITZ, H
    AURELL, M
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1986, 293 (6545): : 471 - 474
  • [4] BRUNNER FP, 1992, KIDNEY INT, V42, pS4
  • [5] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [6] THE KIDNEY IN MATURITY ONSET DIABETES-MELLITUS - A CLINICAL-STUDY OF 510 PATIENTS
    FABRE, J
    BALANT, LP
    DAYER, PG
    FOX, HM
    VERNET, AT
    [J]. KIDNEY INTERNATIONAL, 1982, 21 (05) : 730 - 738
  • [7] ANGIOTENSIN CONVERTING ENZYME-INHIBITORS VERSUS CALCIUM-ANTAGONISTS IN THE TREATMENT OF DIABETIC HYPERTENSIVE PATIENTS
    FERDER, L
    DACCORDI, H
    MARTELLO, M
    PANZALIS, M
    INSERRA, F
    [J]. HYPERTENSION, 1992, 19 (02) : 237 - 242
  • [8] RECEPTOR MEDIATED UPTAKE OF APO-B AND APO-E RICH LIPOPROTEINS BY HUMAN GLOMERULAR EPITHELIAL-CELLS
    GRONE, HJ
    WALLI, AK
    GRONE, E
    KRAMER, A
    CLEMENS, MR
    SEIDEL, D
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (06) : 1449 - 1459
  • [9] SIMILAR RISKS OF NEPHROPATHY IN PATIENTS WITH TYPE-I OR TYPE-II DIABETES-MELLITUS
    HASSLACHER, C
    RITZ, E
    WAHL, P
    MICHAEL, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (10) : 859 - 863
  • [10] PLASMA-LIPOPROTEINS AND RENAL-FUNCTION DURING SIMVASTATIN TREATMENT IN DIABETIC NEPHROPATHY
    HOMMEL, E
    ANDERSEN, P
    GALL, MA
    NIELSEN, F
    JENSEN, B
    ROSSING, P
    DYERBERG, J
    PARVING, HH
    [J]. DIABETOLOGIA, 1992, 35 (05) : 447 - 451